CHD/Prevention News

Older cancer survivors exhibited increased risk for cardiovascular disease than cancer-free individuals of the same age, according to a secondary analysis of a randomized study.

CHICAGO — The presence of breast arterial calcifications on routine mammograms may signal increased risk for atherosclerotic CVD later in life, according to research presented at the Annual Meeting of The Menopause Society.

For nearly 2 decades, George L. Bakris, MD, was a pillar of the Cardiometabolic Health Congress, sharing his expertise, passion and unwavering dedication to advancing cardiometabolic health.

Novo Nordisk announced that monlunabant, a novel small molecule oral cannabinoid receptor 1 inverse agonist, was associated with weight loss in a phase 2a study of people with obesity and metabolic syndrome.

Exposure to toxic metals such as cadmium and tungsten was associated with increased coronary calcium progression, a significant predictor of atherosclerosis, according to data published in the Journal of the American College of Cardiology.

Higher levels of life satisfaction and well-being may portend lower rates of CVD due to the association between inflammatory markers and CV risk factors observed among individuals reporting lower well-being, researchers reported.

Adults who drink caffeinated beverages such as coffee or tea may have a lower risk for developing multiple cardiometabolic diseases compared with adults with low or no intake, according to study findings.

Many recently recalled cardiovascular devices did not undergo premarket testing prior to FDA approval, and postmarket studies of the devices were slow and infrequent, researchers reported.

Catching up on sleep over the weekend was associated with lower likelihood of having heart disease compared with individuals who slept less than they would during the week, a speaker reported.

In patients with obesity and heart disease, semaglutide 2.4 mg reduced risk for major adverse cardiovascular events regardless of baseline kidney function, according to new data from the SELECT trial.